Teva Pharmaceutical Industries | TEVA - Selling And Administration Expenses

Stock Price
9,330.00
Daily Change
91.00 0.99%
Monthly
-7.26%
Yearly
76.54%
Q2 Forecast
9,052.90

Teva Pharmaceutical Industries reported $1.12B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Guangzhou Baiy CNY 2.23B 480.92M Dec/2025
Jiangsu Hengrui CNY 3.01B 227.63M Dec/2025
Kalbe Farma IDR 2.51T 410.17B Sep/2025
Richter Gedeon HUF 52.3B 6.68B Sep/2025
Sh Fosun Pharma CNY 4.44B 1.32B Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025